GLP-1 medications are widely discussed in weight loss and diabetes conversations, but the language can sound technical and a bit off-putting at first
Tirzepatide, a revolutionary peptide medication, has gained attention for its powerful effects on weight loss and blood sugar control
Peterhoff, M
What plan sponsors are watching Alberta Blue Cross identifies several factors shaping GLP-1 plan costs through 2026: Expanded potential uses beyond diabetes and obesity, including MASH and OSA [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] A robust pipeline of new GLP-1 therapies under development [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] Shift toward longer-acting and oral formulations [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php] A semaglutide generic expected mid-2026 [Source: benefitscanada.com/benefits/health-benefits/expanded-use-of-glp-1s-a-major-driver-of-drug-plan-costs-in-2026-report/] Canadians assessing their options can review our insurance coverage checker or visit the FAQ for pricing and regulatory context
The compounded semaglutide was customized for you based on a specific medical need: The FDA ruled that from April 22, 2025 onward, pharmacists can only make compounded semaglutide for a patient if the patient's doctor explains why the FDA-approved version doesnt work for them (like if a patient is allergic to a dye in the medication, or needs it in oral form because they cant do injections)
Individual patient eligibility for drug therapies available through Sesame are determined by the assessment of appropriateness of each therapy by the Sesame-listed provider and are subject to availability
